Long-term follow-up study of community-based patients receiving XR-NTX for opioid use disorders.

Arthur Robin WilliamsVincent BarbieriKaitlyn MishlenFrances R LevinEdward V NunesJohn J MarianiAdam Bisaga

Published in: The American journal on addictions (2017)

Among outpatients who successfully receive 3 monthly XR-NTX injections, many will prematurely discontinue treatment due to internal attitudes, such as "feeling cured." (Am J Addict 2017;26:319-325).

Keyphrases

combination therapy
platelet rich plasma
replacement therapy